Noemı́ Reguart
Impact in
- Oncology top 0.5%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 115
- Lung Cancer Research Studies 42
- Cancer Immunotherapy and Biomarkers 34
- Colorectal Cancer Treatments and Studies 20
-
- Lung Cancer Treatments and Mutations 109
- Lung Cancer Diagnosis and Treatment 35
- Co-authors
- David M. JablonsLiang YouBiao HeIwao MikamiZhidong XuRafael RosellMiquel TarónJulien Mazières
- Journals
- Journal of Clinical Oncology (21 papers)Journal of Thoracic Oncology (20 papers)Lung Cancer (12 papers)Annals of Oncology (11 papers)Cancer Research (9 papers)
- Partner nations
- SpainUnited StatesFrance
In The Last Decade
Noemı́ Reguart
165 papers receiving 5.4k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Oncology 2.9k
- Pulmonary and Respiratory Medicine 2.6k
- Cancer Research 875
- Molecular Biology 2.5k
- Immunology 419
Countries citing papers authored by Noemı́ Reguart
This map shows the geographic impact of Noemı́ Reguart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noemı́ Reguart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noemı́ Reguart more than expected).
Fields of papers citing papers by Noemı́ Reguart
This network shows the impact of papers produced by Noemı́ Reguart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noemı́ Reguart. The network helps show where Noemı́ Reguart may publish in the future.
Co-authors
The 25 scholars most cited alongside Noemı́ Reguart, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 6 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 18 | |
| 6 | 2024 | 17 | |
| 7 | 2023 | 6 | |
| 8 | 2022 | 3 | |
| 9 | 2022 | 22 | |
| 10 | 2021 | 5 | |
| 11 | 2021 | 12 | |
| 12 | 2021 | 6 | |
| 13 | 2021 | 40 | |
| 14 | 2020 | 4 | |
| 15 | 2019 | 33 | |
| 16 | 2018 | 122 | |
| 17 | 2017 | 277 | |
| 18 | 2017 | 36 | |
| 19 | 2014 | 72 | |
| 20 | Usefulness of predictive tests for cancer treatment. | 2006 | 16 |
About Noemı́ Reguart
Noemı́ Reguart is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Immunology and Allergy, having authored 175 papers that have together received 5.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (109 papers), Lung Cancer Research Studies (42 papers), Lung Cancer Diagnosis and Treatment (35 papers), Cancer Immunotherapy and Biomarkers (34 papers), Cancer Genomics and Diagnostics (29 papers), Colorectal Cancer Treatments and Studies (20 papers), Cancer-related gene regulation (14 papers) and Wnt/β-catenin signaling in development and cancer (12 papers). The work is most often cited by research in Oncology (2.9k citations), Pulmonary and Respiratory Medicine (2.6k citations), Cancer Research (875 citations), Molecular Biology (2.5k citations) and Immunology (419 citations). Noemı́ Reguart has collaborated with scholars based in Spain, United States and France. Frequent co-authors include David M. Jablons, Liang You, Biao He, Iwao Mikami, Zhidong Xu, Rafael Rosell, Miquel Tarón, Julien Mazières, Jordi Remón and Frank McCormick. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Lung Cancer, Annals of Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.